149 related articles for article (PubMed ID: 3937284)
1. Inhibition of platelet aggregation in whole blood by adrenoceptor antagonists.
Greer IA; Walker JJ; Calder AA; Forbes CD
Thromb Res; 1985 Dec; 40(5):631-43. PubMed ID: 3937284
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of whole blood platelet aggregation by nicardipine, and synergism with prostacyclin in-vitro.
Greer IA; Walker JJ; McLaren M; Calder AA; Forbes CD
Thromb Res; 1986 Feb; 41(4):509-18. PubMed ID: 3083526
[TBL] [Abstract][Full Text] [Related]
3. Effect of prostacyclin (epoprostenol) on the aggregation of human platelets in whole blood in vitro.
Saniabadi AR; Lowe GD; Belch JJ; Barbenel JC; Forbes CD
Haemostasis; 1984; 14(6):487-94. PubMed ID: 6442909
[TBL] [Abstract][Full Text] [Related]
4. Influence of some beta blockers (pindolol, atenolol, timolol and metoprolol) on aggregation and arachidonic acid metabolism in human platelets.
Srivastava KC
Prostaglandins Leukot Med; 1987 Sep; 29(1):79-84. PubMed ID: 2890173
[TBL] [Abstract][Full Text] [Related]
5. A comparative study of the effects of adrenoceptor antagonists on platelet aggregation and thromboxane generation.
Greer IA; Walker JJ; McLaren M; Calder AA; Forbes CD
Thromb Haemost; 1985 Aug; 54(2):480-4. PubMed ID: 2867620
[TBL] [Abstract][Full Text] [Related]
6. Influence on platelet activity and red cell fluidity of epoprostenol and two stable prostacyclin analogues in vitro.
Maurin N
Arzneimittelforschung; 1986 Aug; 36(8):1180-3. PubMed ID: 3096342
[TBL] [Abstract][Full Text] [Related]
7. Comparison of inhibitory actions of prostacyclin and a new prostacyclin analogue on the aggregation of human platelet in whole blood.
Saniabadi AR; Belch JJ; Lowe GD; Barbenel JC; Forbes CD
Haemostasis; 1987; 17(3):147-53. PubMed ID: 2440771
[TBL] [Abstract][Full Text] [Related]
8. Synergistic inhibitory effects of adrenoceptor antagonists and prostacyclin, and umbilical artery-derived prostacyclin-like activity on platelet aggregation.
Greer IA; McLaren M; Forbes CD
Eur J Obstet Gynecol Reprod Biol; 1990; 35(2-3):109-18. PubMed ID: 1970789
[TBL] [Abstract][Full Text] [Related]
9. The novel effect of a new prostacyclin analogue ZK36374 on the aggregation of human platelets in whole blood.
Saniabadi AR; Lowe GD; Belch JJ; Forbes CD; Prentice CR; Barbenel JC
Thromb Haemost; 1983 Oct; 50(3):718-21. PubMed ID: 6196854
[TBL] [Abstract][Full Text] [Related]
10. Influence of propranolol, pindolol, practolol and talinolol on arachidonic acid (AA)- and U-46619-induced aggregation and on AA-induced thromboxane A2 formation in platelets.
Heinroth I; Block HU; Pönicke K; Förster W
Prostaglandins Leukot Med; 1983 Oct; 12(2):189-206. PubMed ID: 6139824
[TBL] [Abstract][Full Text] [Related]
11. Platelet sensitivity to prostacyclin in pregnancy and uterine cancer.
Briel RC; Lippert TH
Eur J Obstet Gynecol Reprod Biol; 1981 Jun; 12(1):19-23. PubMed ID: 7018952
[TBL] [Abstract][Full Text] [Related]
12. Beta-adrenoceptor antagonists and human platelets: relationship of effects to lipid solubility.
Kerry R; Scrutton MC; Wallis RB
Biochem Pharmacol; 1984 Aug; 33(16):2615-22. PubMed ID: 6147145
[TBL] [Abstract][Full Text] [Related]
13. A chemically stable analogue, 9 beta-methyl carbacyclin, with similar effects to epoprostenol (prostacyclin, PGI2) in man.
O'Grady J; Hedges A; Whittle BJ; Al-Sinawi LA; Mekki QA; Burke C; Moody SG; Moti MJ; Hassan S
Br J Clin Pharmacol; 1984 Dec; 18(6):921-33. PubMed ID: 6085004
[TBL] [Abstract][Full Text] [Related]
14. Effects of methylprednisolone and hydrocortisone on aggregation of rabbit platelets induced by arachidonic acid and other aggregating substances.
Glass F; Lippton H; Kadowitz PJ
Thromb Haemost; 1981 Dec; 46(4):676-9. PubMed ID: 6800048
[TBL] [Abstract][Full Text] [Related]
15. Critical evaluation of platelet aggregation in whole human blood.
Riess H; Braun G; Brehm G; Hiller E
Am J Clin Pathol; 1986 Jan; 85(1):50-6. PubMed ID: 3079628
[TBL] [Abstract][Full Text] [Related]
16. Effects of propranolol in vitro and in vivo on platelet function and thromboxane formation in normal volunteers.
Siess W; Lorenz R; Roth P; Weber PC
Agents Actions; 1983 Feb; 13(1):29-34. PubMed ID: 6344593
[TBL] [Abstract][Full Text] [Related]
17. Platelet impedance aggregation in whole blood and its inhibition by antiplatelet drugs.
Mackie IJ; Jones R; Machin SJ
J Clin Pathol; 1984 Aug; 37(8):874-8. PubMed ID: 6206096
[TBL] [Abstract][Full Text] [Related]
18. The in vitro effect of amrinone on platelet aggregation in human whole blood.
Pattison A; Eason CT; Bonner FW
Res Commun Chem Pathol Pharmacol; 1986 Feb; 51(2):261-4. PubMed ID: 3083485
[TBL] [Abstract][Full Text] [Related]
19. Benzodiazepines inhibit human platelet activation: comparison of the mechanism of antiplatelet actions of flurazepam and diazepam.
Romstedt K; Huzoor-Akbar
Thromb Res; 1985 May; 38(4):361-74. PubMed ID: 2990062
[TBL] [Abstract][Full Text] [Related]
20. Platelet dysfunction in uremia. II. Correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adenosine diphosphate or collagen.
Di Minno G; Cerbone A; Usberti M; Cianciaruso B; Cortese A; Farace MJ; Martinez J; Murphy S
J Lab Clin Med; 1986 Sep; 108(3):246-52. PubMed ID: 3018111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
